No Detail Found!

Efficacy and safety of rosuvastatin compared to simvaststin in coronary artery disease.

Author(s)
Shimal Khan Department of Pharmacology, Gomal Medical College Dera Ismail Khan, Pakistan
Amjad Abrar Punjab Institute of Cardiology, Lahore, Pakistan
Ahmad Rafique Punjab Institute of Cardiology, Lahore, Pakistan
Abdul Rehman Abid Punjab Institute of Cardiology, Lahore, Pakistan
Tehmina Jan Khyper Medical College, Peshawar, Pakistan
Abstract
Background: Coronary artery disease is the leading cause of morbidity and mortality worldwide. Hyperlipidemia is a major risk factor for it. This trial was conducted to compare the efficacy and safety of rosuvastatin and simvastatin in patients with coronary artery disease. Material & Methods: This study was conducted at Pharamacology Department, Gomal Medical College, D.I.Khan from May 1, 2008 to December 31, 2008. Patients with history of coronary artery disease were randomized to receive Rosuvastatin 5mg or Simvastatin 20mg for six weeks. Primary end point was number of patients achieving National Cholesterol Education Program Adult Treatment Panel (NCEP ATP III) target LDL-C
Publication Details
Page(s) 64-69
DOI DOI not available
Published Journal: Gomal Journal of Medical Sciences, Volume: 8, Issue: 1, Year: 2010

Request the full text from PASTIC

0

Citations

0

Downloads

89

Views